Emmanuel U. Azu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Emmanuel U. Azu has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Gulzar Hussain Shah
Department of Health Policy and Community Health, Jiann-Ping Hsu College of Public Health, Georgia Southern University, Statesboro, GA 30458, USA
3 shared publications - Timothy Kizza
Department of Biostatistics, Epidemiology and Environmental Science, Jiann-Ping Hsu College of Public Health, Georgia Southern University, Statesboro, GA 30458, USA
3 shared publications - Ibrahim Alliu
Department of Biostatistics, Epidemiology, and Environmental Health Science, Jiann-Ping Hsu College of Public Health, Georgia Southern University, Statesboro, GA 30460, USA
2 shared publications - Lili Yu
Georgia Southern University
2 shared publications - Logan Thomas Cowan
Department of Biostatistics, Epidemiology, and Environmental Health Science, Jiann-Ping Hsu College of Public Health, Georgia Southern University, Statesboro, GA 30460, USA
2 shared publications - Subash Thapa
Department of Biostatistics, Epidemiology, and Environmental Health Science, Jiann-Ping Hsu College of Public Health, Georgia Southern University, Statesboro, GA 30460, USA
2 shared publications
Latest Publications
- Open Access
Heterogeneous Effects of Cesarean Delivery Across Maternal and Infant Outcomes Using Population-Based Causal Machine Learning
Cesarean delivery is associated with maternal and infant outcomes, but population-average estimates may obscure variation across individuals. This study examined associations between delivery mode and four maternal and infant outcomes and explored heterogeneity in estimated treatment effects. We analyzed Pregnancy Risk Assessment Monitoring System (PRAMS) data from 2016–2020, including 197,942 women with classifiable delivery modes. Least absolute shrinkage and selection operator regression was used for covariate screening, followed by extreme gradient boosting for propensity score estimation. Stabilized inverse-probability-of-treatment weights were combined with PRAMS analytic weights for population-average logistic regression. An X-learner framework was applied to explore heterogeneity in estimated treatment effects across baseline maternal and pregnancy characteristics. Compared with vaginal delivery, cesarean delivery was associated with higher odds of infant transfer (OR, 2.27; 95% CI, 1.99–2.60; p < 0.001) and postpartum depressive symptoms (OR, 1.11; 95% CI, 1.06–1.16; p < 0.001), and lower odds of breastfeeding initiation (OR, 0.85; 95% CI, 0.81–0.88; p < 0.001). The estimated odds of infant death were lower but not statistically significant (OR, 0.77; 95% CI, 0.57–1.03; p = 0.082). Exploratory X-learner analyses indicated greater heterogeneity for infant transfer and breastfeeding initiation, whereas postpartum depressive symptoms and infant death exhibited comparatively limited variability in estimated conditional effects. Cesarean delivery was associated with differential maternal and infant outcomes, with estimated heterogeneity varying across outcomes. Combining population-average regression with exploratory machine learning approaches may provide additional insight into these associations. However, residual confounding, particularly by clinical indication, and the lack of external validation limit causal interpretation and immediate clinical application.
Open AccessHeterogeneous Effects of Cesarean Delivery Across Maternal and Infant Outcomes Using Population-Based Causal Machine Learning
Cesarean delivery is associated with maternal and infant outcomes, but population-average estimates may obscure variation across individuals. This study examined associations between delivery mode and four maternal and infant outcomes and explored heterogeneity in estimated treatment effects. We analyzed Pregnancy Risk Assessment Monitoring System (PRAMS) data from 2016–2020, including 197,942 women with classifiable delivery modes. Least absolute shrinkage and selection operator regression was used for covariate screening, followed by extreme gradient boosting for propensity score estimation. Stabilized inverse-probability-of-treatment weights were combined with PRAMS analytic weights for population-average logistic regression. An X-learner framework was applied to explore heterogeneity in estimated treatment effects across baseline maternal and pregnancy characteristics. Compared with vaginal delivery, cesarean delivery was associated with higher odds of infant transfer (OR, 2.27; 95% CI, 1.99–2.60; p < 0.001) and postpartum depressive symptoms (OR, 1.11; 95% CI, 1.06–1.16; p < 0.001), and lower odds of breastfeeding initiation (OR, 0.85; 95% CI, 0.81–0.88; p < 0.001). The estimated odds of infant death were lower but not statistically significant (OR, 0.77; 95% CI, 0.57–1.03; p = 0.082). Exploratory X-learner analyses indicated greater heterogeneity for infant transfer and breastfeeding initiation, whereas postpartum depressive symptoms and infant death exhibited comparatively limited variability in estimated conditional effects. Cesarean delivery was associated with differential maternal and infant outcomes, with estimated heterogeneity varying across outcomes. Combining population-average regression with exploratory machine learning approaches may provide additional insight into these associations. However, residual confounding, particularly by clinical indication, and the lack of external validation limit causal interpretation and immediate clinical application.
- Open Access
- 14 October 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (20) , 3427
Long COVID and Incident Multimorbidity in the United States: Evidence from a Nationally Representative Longitudinal Study
Background/Objectives: Long COVID has been associated with elevated risks of individual chronic conditions, but its association with the transition to multimorbidity remains unclear. This study aims to examine whether retrospective COVID-19 status was associated with incident multimorbidity among U.S. adults. Methods: We analyzed Panel 24 of the Medical Expenditure Panel Survey (MEPS; 2019–2022), including 4356 individuals free of multimorbidity at baseline. COVID-19 exposure was classified as Long COVID, COVID-19-recovered, or no COVID-19. Survey-weighted logistic regression estimated associations between retrospective COVID-19 status and incident cross-domain multimorbidity, and generalized estimating equations assessed healthcare expenditures, health-related quality of life, and inpatient utilization. Results: Incident MM occurred in 106 participants: 17 with Long COVID, 41 COVID-19-recovered, and 48 with no COVID-19. In the primary model (4239 participants; 105 events), Long COVID was associated with higher odds of incident MM than no COVID-19 (OR 2.34; 95% CI, 1.14–4.79); the estimate for COVID-19-recovered participants was OR 1.71 (95% CI, 1.01–2.92). Fully adjusted and Firth estimates were directionally consistent. Cardiometabolic plus respiratory MM predominated (79/106). COVID-status-by-year interactions were not significant for total expenditures, out-of-pocket expenditures, physical or mental health scores, or inpatient stays. Conclusions: Retrospectively classified Long COVID was associated with incident cross-domain MM recorded during follow-up, but temporal ordering cannot be established, and sparse events limit precision. Replication with prospectively timed exposure and diagnosis data is needed.
- 14 October 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (20) , 3427
Open AccessLong COVID and Incident Multimorbidity in the United States: Evidence from a Nationally Representative Longitudinal Study
Background/Objectives: Long COVID has been associated with elevated risks of individual chronic conditions, but its association with the transition to multimorbidity remains unclear. This study aims to examine whether retrospective COVID-19 status was associated with incident multimorbidity among U.S. adults. Methods: We analyzed Panel 24 of the Medical Expenditure Panel Survey (MEPS; 2019–2022), including 4356 individuals free of multimorbidity at baseline. COVID-19 exposure was classified as Long COVID, COVID-19-recovered, or no COVID-19. Survey-weighted logistic regression estimated associations between retrospective COVID-19 status and incident cross-domain multimorbidity, and generalized estimating equations assessed healthcare expenditures, health-related quality of life, and inpatient utilization. Results: Incident MM occurred in 106 participants: 17 with Long COVID, 41 COVID-19-recovered, and 48 with no COVID-19. In the primary model (4239 participants; 105 events), Long COVID was associated with higher odds of incident MM than no COVID-19 (OR 2.34; 95% CI, 1.14–4.79); the estimate for COVID-19-recovered participants was OR 1.71 (95% CI, 1.01–2.92). Fully adjusted and Firth estimates were directionally consistent. Cardiometabolic plus respiratory MM predominated (79/106). COVID-status-by-year interactions were not significant for total expenditures, out-of-pocket expenditures, physical or mental health scores, or inpatient stays. Conclusions: Retrospectively classified Long COVID was associated with incident cross-domain MM recorded during follow-up, but temporal ordering cannot be established, and sparse events limit precision. Replication with prospectively timed exposure and diagnosis data is needed.
- Open Access
Multimorbidity Patterns and Mortality Risk in a National Sample of US Adults Identified Using Latent Class Analysis
Background/Objectives: Multimorbidity is increasingly recognized as a major contributor to mortality worldwide, yet its underlying patterns and prognostic implications remain poorly understood in the United States. This study identified distinct multimorbidity patterns and examined their association with all-cause mortality in a nationally representative sample of U.S. adults. Methods: We conducted a retrospective cohort study using data from the 2004 National Health Interview Survey linked to the National Death Index through 2019 (n = 28,598). Latent class analysis identified unobserved multimorbidity classes based on patterns of co-occurring physician-diagnosed chronic conditions, and Cox proportional hazards models were fitted to estimate mortality risk while accounting for complex survey design. Six distinct multimorbidity classes were identified, reflecting cardiometabolic, respiratory, cardiovascular, and inflammatory disease profiles. Results: Compared with the Low Multimorbidity group, all other classes were associated with increased mortality risk. In fully adjusted analyses, the Severe Cardiopulmonary–Metabolic (HR 3.71, 95% CI 2.99–4.60) and Advanced Cardiovascular (HR 2.81, 95% CI 2.52–3.14) classes showed the highest risks. Intermediate risks were observed in the Cardiometabolic–Arthritis (HR 2.45, 95% CI 2.13–2.81) and Respiratory–Musculoskeletal (HR 1.39, 95% CI 1.22–1.58) classes, while the Inflammatory Pain–Airway class showed a more modest increase. Subgroup analyses suggested stronger relative effects among younger adults and women in the most severe classes. Conclusions: The study findings highlight the heterogeneous nature of multimorbidity and suggest that specific disease clusters carry substantially different mortality risks. Recognizing these patterns may improve risk stratification and support more targeted, patient-centered care strategies.
Open AccessMultimorbidity Patterns and Mortality Risk in a National Sample of US Adults Identified Using Latent Class Analysis
Background/Objectives: Multimorbidity is increasingly recognized as a major contributor to mortality worldwide, yet its underlying patterns and prognostic implications remain poorly understood in the United States. This study identified distinct multimorbidity patterns and examined their association with all-cause mortality in a nationally representative sample of U.S. adults. Methods: We conducted a retrospective cohort study using data from the 2004 National Health Interview Survey linked to the National Death Index through 2019 (n = 28,598). Latent class analysis identified unobserved multimorbidity classes based on patterns of co-occurring physician-diagnosed chronic conditions, and Cox proportional hazards models were fitted to estimate mortality risk while accounting for complex survey design. Six distinct multimorbidity classes were identified, reflecting cardiometabolic, respiratory, cardiovascular, and inflammatory disease profiles. Results: Compared with the Low Multimorbidity group, all other classes were associated with increased mortality risk. In fully adjusted analyses, the Severe Cardiopulmonary–Metabolic (HR 3.71, 95% CI 2.99–4.60) and Advanced Cardiovascular (HR 2.81, 95% CI 2.52–3.14) classes showed the highest risks. Intermediate risks were observed in the Cardiometabolic–Arthritis (HR 2.45, 95% CI 2.13–2.81) and Respiratory–Musculoskeletal (HR 1.39, 95% CI 1.22–1.58) classes, while the Inflammatory Pain–Airway class showed a more modest increase. Subgroup analyses suggested stronger relative effects among younger adults and women in the most severe classes. Conclusions: The study findings highlight the heterogeneous nature of multimorbidity and suggest that specific disease clusters carry substantially different mortality risks. Recognizing these patterns may improve risk stratification and support more targeted, patient-centered care strategies.
- Open Access
- 29 May 2026
- Published by MDPI AG in Preprints.org
Long COVID as a Predictor of Incident Multimorbidity Among U.S. Civilians- Nationally Representative Evidence on Risk, and Downstream Burden
Long COVID has been associated with elevated risks of individual chronic conditions, but its role in the transition to multimorbidity remains unclear. We analyzed MEPS Panel 24 (2019-2022) data from 4,364 adults free of multimorbidity at baseline. COVID-19 exposure was classified as Long COVID, COVID-recovered, or no COVID. Discrete-time survival models estimated incident multimorbidity risk, and generalized estimating equations assessed healthcare expenditures, health-related quality of life, and inpatient utilization. Long COVID was associated with a 2.54-fold higher hazard of incident multimorbidity compared with no COVID (HR = 2.54; 95% CI: 1.26-5.10), while COVID-recovered participants also had elevated hazard (HR = 1.85; 95% CI: 1.08-3.17). Incident multimorbidity onset was associated with lower physical HRQoL, increased inpatient utilization, and higher healthcare expenditures. Long COVID was independently associated with lower mental HRQoL, while evidence for Long COVID-specific expenditure growth was model-dependent. These findings suggest that Long COVID and resolved COVID-19 infection may increase the risk of transitioning into multimorbidity, supporting integrated chronic disease surveillance, mental health assessment, and coordinated post-COVID care.
- 29 May 2026
- Published by MDPI AG in Preprints.org
Open AccessLong COVID as a Predictor of Incident Multimorbidity Among U.S. Civilians- Nationally Representative Evidence on Risk, and Downstream Burden
Long COVID has been associated with elevated risks of individual chronic conditions, but its role in the transition to multimorbidity remains unclear. We analyzed MEPS Panel 24 (2019-2022) data from 4,364 adults free of multimorbidity at baseline. COVID-19 exposure was classified as Long COVID, COVID-recovered, or no COVID. Discrete-time survival models estimated incident multimorbidity risk, and generalized estimating equations assessed healthcare expenditures, health-related quality of life, and inpatient utilization. Long COVID was associated with a 2.54-fold higher hazard of incident multimorbidity compared with no COVID (HR = 2.54; 95% CI: 1.26-5.10), while COVID-recovered participants also had elevated hazard (HR = 1.85; 95% CI: 1.08-3.17). Incident multimorbidity onset was associated with lower physical HRQoL, increased inpatient utilization, and higher healthcare expenditures. Long COVID was independently associated with lower mental HRQoL, while evidence for Long COVID-specific expenditure growth was model-dependent. These findings suggest that Long COVID and resolved COVID-19 infection may increase the risk of transitioning into multimorbidity, supporting integrated chronic disease surveillance, mental health assessment, and coordinated post-COVID care.